Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Levemir and endothelial function in women with type 2 diabetes mellitus
2006-005175-18Phase 4Terminated
- Sponsor
- Medical University of Innsbruck
- Start
- Aug 2007
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of insulin detemir in type 2 diabetes mellitus (T2DM) (3 arms), sponsored by Medical University of Innsbruck. Primary endpoint: Endothelial function by flow-mediated endothelium-dependent dilation. Started Aug 2007; status: terminated.
02
Drugs
insulin detemir
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on 2006-005175-18.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-005175-18.